MicroCHIPS receives 2010 Edison Best New Product Award for Illume System

NewsGuard 100/100 Score

MicroCHIPS, Inc., a developer of intelligent implant systems, today announced that it has received a 2010 Edison Best New Product Award™ for its Illume™ product. The product was awarded Gold in the Science and Medical Category, recognizing the benefit that it will bring to millions of people with diabetes who must manage their blood sugar intensively to stay healthy.

"We are very honored to receive this award, as it demonstrates our innovative approach and the value that our product can bring to people who struggle daily with the demands of insulin-requiring diabetes," said Ajit Gill, president and CEO of MicroCHIPS. "By applying our unique microreservoir technology to create long-lived, in-body glucose sensors, we believe we can help people manage their diabetes with much more ease and with better results."  

The Illume™ Continuous Glucose Management System is being created as part of the next generation of consumer-focused diabetes management tools.  The system is a long-term, multi-sensor implant designed to wirelessly deliver continuous, convenient, reliable and accurate glucose measurements for a full year.  Designed to be placed just under the skin, this breakthrough product is currently undergoing testing with the goal of reaching the market in the next few years.

"Innovation is more important now than ever," said Sarah Miller Caldicott, great grand-niece of Thomas Edison and Chair of the Edison Best New Product Awards. "The Edison Award winners are the moving parts in the engine of economic growth. They inspire people to think outside the box and improve the lives of people around the world."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Advanced insulin pumps enhance blood sugar management in type 1 diabetes